Know what happened. Move on.

U.S.

Thursday, Nov 5

U.S.

Nevada Man Indicted for Making Threats to Kill the President of the United States

  • On October 16, 2026, the Las Vegas Metropolitan Police Department executed a search warrant at Utlaut’s residence and vehicle in Henderson, Nevada.
  • Arraignment has been scheduled before United States Magistrate Judge Maximiliano D. Couvillier III on November 18, 2026.
  • During the search, 15 firearms, together with multiple firearm magazines and ammunition, were seized.

Department of Justice · Official source · Updated

Wednesday, Nov 4

Tuesday, Nov 3

Monday, Nov 2

Wednesday, Oct 21

U.S.

Augusta businessman fails to forward payroll taxes to IRS

  • A Kansas business owner was sentenced to 12 months and one day in prison for failing to forward payroll taxes paid by his employees to the Internal Revenue Service (IRS).
  • Tax preparer sentenced to prison A Kansas tax preparer was sentenced to 36 months in prison for filing false income tax returns for his clients leading to a tax loss of more than $1.5 million.

Department of Justice · Official source · Updated

Tuesday, Oct 20

U.S.

FDA Approves First-of-Its

  • FDA approved antisense oligonucleotide to treat chronic hepatitis B.

Food and Drug Administration · Official source · Updated

Monday, Oct 19

Friday, Oct 16

Wednesday, Oct 14

Thursday, Sep 10

U.S.

S. 858 Signed into Law

  • S. 858 authorizes the National Medal of Honor Museum Foundation to establish a commemorative work on the National Mall.

White House · Official source · Updated

U.S.

Trump Dividend

  • President Donald J. Trump unveiled the Trump Dividend — a historic $5,000 cash payment to every adult American citizen.
  • If the Republicans win the House of Representatives and the United States Senate, President Trump promises to issue a dividend to every adult citizen in the United States of America for $5,000.

White House · Official source · Updated

Wednesday, Sep 9

Tuesday, Sep 8

U.S.

FDA Grants Accelerated Approval to a New Breast Cancer Treatment

  • The U.S. Food and Drug Administration granted accelerated approval to Etcamah (camizestrant) in combination with a CDK4/6 inhibitor for the treatment of adult patients with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
  • The FDA also authorized the Guardant360 CDx assay as a companion diagnostic device to identify patients with breast cancer with ESR1 mutations for treatment with camizestrant.
  • The accelerated approval was granted to AstraZeneca.

+3 more

Food and Drug Administration · Official source · Updated

U.S.

U.S. International Trade in Goods and Services

  • International Trade is the official source for U.S. export and import statistics.
  • International Trade is responsible for issuing regulations governing the reporting of all export shipments from the United States.

U.S. Census Bureau · Official source · Updated